Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

January 15, 2014 (Vol. 34, No. 2)

Setting Sights on Ocular Disorders

New Therapeutic Options Are in Development for Age-Related Macular Degeneration

  • Age-related macular degeneration (AMD) is one of the leading causes of blindness. There are two forms of AMD—wet and dry. Currently, the majority of therapeutics being developed are for wet AMD ( Figure ). The standard therapy for wet AMD is anti-VEGF injections. The benefit of these injections ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.